Paper Details

  1. Home
  2. Paper Details

Triazolam impairs inhibitory control of behavior in humans.

Author: FillmoreM T, HaysL, KellyT H, RushC R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This study investigated the effects of triazolam, a sedative-hypnotic drug, on the ability to inhibit behavior in humans. Triazolam reduced response inhibitions, increased the time required to inhibit responses, and slowed the activation of responses, indicating its potential to produce behavioral disinhibition.
Paper Details　
Original Abstract of the Article :
This study tested the effects of the sedative-hypnotic drug triazolam (Halcion) on the ability to inhibit behavior in humans. Thirty adults practiced a stop-signal task that measured their ability to inhibit and activate behavioral responses on a choice reaction time task. Equal numbers of participa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1037//1064-1297.9.4.363

データ提供：米国国立医学図書館（NLM）

Triazolam Impairs Inhibitory Control of Behavior in Humans

This research delves into the intricate world of human behavior, specifically investigating the effects of triazolam, a sedative-hypnotic drug, on the ability to inhibit behavior. The authors, like skilled desert explorers venturing into the depths of human cognition, designed an experiment to assess the impact of triazolam on behavioral control.

Triazolam's Disinhibiting Effects

The study's findings demonstrate that triazolam significantly impaired the ability to inhibit behavioral responses, suggesting that this drug can lead to states of behavioral disinhibition. This discovery, much like a desert mirage creating an illusion of water, highlights the complex interplay between drugs and brain function.

Implications for Drug Use

The study emphasizes the importance of understanding the potential behavioral effects of sedative-hypnotic drugs, particularly in individuals prone to impulsivity or disinhibition. This knowledge, much like a desert guide's awareness of hidden dangers, can help minimize the risks associated with these medications.

Dr.Camel's Conclusion

This research highlights the complex relationship between drugs and behavior, underscoring the importance of responsible drug use and the need for careful consideration of potential side effects. It's a reminder that even seemingly harmless substances can have unexpected consequences, much like the desert's deceptive beauty can mask hidden dangers.
Date :
  1. Date Completed 2002-05-13
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

11764012

DOI: Digital Object Identifier

10.1037//1064-1297.9.4.363

Related Literature

Article Analysis
・Effects of triazolam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.